AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
about
Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algaePancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cellsGrape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway.The molecular targets for the diagnosis and treatment of pancreatic cancer.Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylationEnhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activationSensitization of squamous cell carcinoma to cisplatin induced killing by natural agentsThe phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.The role of Akt activation in the response to chemotherapy in pancreatic cancerClusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancerApoptotic pathways in pancreatic ductal adenocarcinomaTargeting synuclein-gamma to counteract drug resistance in cancer.RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase.Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies.Role of autophagy in apoptotic regulation by Akt in pancreatic cancerFKBP51 protects 661w cell culture from staurosporine-induced apoptosis.Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas.RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance.Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10.
P2860
Q28484635-7379DA12-5E68-463E-88C0-33EF17F6367FQ28486199-3441A89B-E32C-49F3-9D07-1B688DE831F0Q30499567-A384A8AF-EEF6-4416-AE35-5DCF24B29030Q33792279-3A120361-F309-4E80-9C0C-212056AE7007Q34384695-183D7BA8-2028-4902-AAEA-98EEA33FBDD8Q34494019-75773296-B607-4ABB-A0C4-A362FC84A76DQ34680322-EA347CD1-31E1-4243-8C38-977C3DF22E87Q34721443-B2B781ED-2604-4FD2-B4F8-3B1A49FEB530Q35100914-DE77B38D-56FB-4708-9D8D-649485E4A693Q35578720-02772A1C-4410-4A41-B981-871F867786F9Q35719620-18BDAD5B-0FDC-4EC1-92BD-862EA403A1D4Q35741836-64B461D3-5B7A-4F6D-980C-FE7949068887Q35954519-48FC97EE-47CC-44AF-A070-C722046C9CFDQ35983641-D39CCA16-EB1F-400F-9483-09838FE2085FQ36020360-A7853D84-429B-4126-B9B8-5B10825BA7D1Q36182734-2A96BB1B-AF3A-40DE-A6AD-6F0B065B16E3Q36648105-82548083-F8E0-4244-96A2-1D69F7D41A23Q36773130-9277246E-903E-4454-A28C-480A74D133D5Q36835642-FEEE5462-BEF5-4BBA-9B0C-0C55B6A2DFA1Q37030872-55ECB9E1-409A-4AA8-893C-84B391479DEFQ37324457-4F1D7B41-2365-4497-BFD9-F64259D49160Q37448131-E2A81073-02A9-462A-9C12-4ED8D5B4617FQ38727311-FA854F01-AB7D-4483-87FC-65E00C1C4120Q38812160-FB1F2DF7-661B-482A-BE3D-D9F8CDA4DD67Q38946429-36525A81-603C-4FBE-8910-B16485BA6260Q39025559-E1EC0DAF-733A-45B2-A00C-69055F2AAD54Q39535549-8EEF55ED-A0C3-465B-8E5B-85E2F81F9BACQ40457650-03ABC901-78F5-423B-B95E-89BCF7442C5FQ40507359-265A0994-EABB-4679-BFD8-A7320E434C3DQ41270773-9DAA3351-AC7E-4325-A584-B3C9C20B9C0AQ41682526-3F55602E-4B8B-4057-8127-69CA0FBDC8E1Q42991719-9AD251D9-0C10-48EF-9D2F-76BD3AA04A07Q45099758-2978F8AC-288C-4788-B407-1F1C17CAF867Q53700817-477BCBA5-E99D-4E63-B49B-68B2842270FA
P2860
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@ast
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@en
type
label
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@ast
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@en
prefLabel
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@ast
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@en
P2093
P2860
P356
P1476
AKT inhibition is associated w ...... ic cancer cell line MIA-PaCa-2
@en
P2093
M Schlieman
S Virudachalam
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601037
P407
P577
2003-07-01T00:00:00Z